Literature DB >> 30910742

Novel patterns in the molecular epidemiology of KPC-producing Klebsiella pneumoniae in Tucumán, Argentina.

Maria A Jure1, Marta E Castillo2, Humberto E Musa3, Carolina G López3, Mariel A Cáceres4, Silvana D Mochi4, Aurore A Bousquet5, Nathalie A Genel6, Guillaume A Arlet7, Dominique C Decré7.   

Abstract

BACKGROUND: In Argentina, there has been an abrupt increase in KPC-2-producing Klebsiella pneumoniae (K. pneumoniae). Tucumán is a multi-border area, so the rapid dissemination of carbapenem-resistant K. pneumoniae is a clinically relevant problem for the region.
OBJECTIVES: This study aimed to investigate the epidemiological and molecular patterns of KPC-producing K. pneumoniae clinical isolates collected from different hospitals in Tucumán.
METHODS: Carbapenem-resistant K. pneumoniae strains were sequentially and uniquely collected during two time periods. Antibiotic susceptibility was determined by the automated Vitex 2® system and using the standard agar dilution test. Multilocus sequence typing and pulsed-field electrophoresis were used for epidemiological analysis. The genetic structures around blaKPC and the encoding genes of extended-spectrum β-lactamases were detected by polymerase chain reaction and sequencing. Plasmids were analysed by conjugation and using the plasmid relaxase gene-typing method.
RESULTS: All 37 isolates were multidrug resistant, and theblaKPC-2 gene was confirmed in all of them. In 17 isolates (45.9%), the blaCTX-M-2 gene was also amplified, as well as blaSHV-2 in five isolates (13.5%) and blaCTX-M-2/blaSHV-2 in four isolates (10.8%). The molecular epidemiology of the blaKPC-2 gene has resulted in it being associated with an IncL/M transferable plasmid disseminating in various sequence types (STs) (ST17, ST556, ST342, ST147, ST461, ST65, ST15 and ST70), and in a new genetic environment with a 764-bp deletion in the ISKpn7-blaKPC region.
CONCLUSIONS: These findings contribute to the understanding of the great diversity of the blaKPC-2-carrying genetic platforms.
Copyright © 2019 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Genetic environment; KPC β-lactamases; Molecular epidemiology

Year:  2019        PMID: 30910742     DOI: 10.1016/j.jgar.2019.02.015

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  4 in total

1.  Genomic and Immunological Characterization of Hypermucoviscous Carbapenem-Resistant Klebsiella pneumoniae ST25 Isolates from Northwest Argentina.

Authors:  Leonardo Albarracin; Ramiro Ortiz Moyano; Juan Martin Vargas; Bruno G N Andrade; Juan Cortez Zamar; Stefania Dentice Maidana; Kohtaro Fukuyama; Shoichiro Kurata; María Ángela Jure; Haruki Kitazawa; Julio Villena
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

2.  Carbapenemase-Producing Klebsiella pneumoniae From Transplanted Patients in Brazil: Phylogeny, Resistome, Virulome and Mobile Genetic Elements Harboring bla KPC- 2 or bla NDM- 1.

Authors:  Otávio Hallal Ferreira Raro; Ravena Maya Cardoso da Silva; Edison Moraes Rodrigues Filho; Teresa Cristina Teixeira Sukiennik; Claudio Stadnik; Cícero Armídio Gomes Dias; Jesús Oteo Iglesias; María Pérez-Vázquez
Journal:  Front Microbiol       Date:  2020-07-15       Impact factor: 5.640

3.  Klebsiella pneumoniae ST307 with OXA-181: threat of a high-risk clone and promiscuous plasmid in a resource-constrained healthcare setting.

Authors:  K A Strydom; L Chen; M M Kock; A C Stoltz; G Peirano; D B Nobrega; M Lowe; M M Ehlers; N M Mbelle; B N Kreiswirth; J D D Pitout
Journal:  J Antimicrob Chemother       Date:  2020-04-01       Impact factor: 5.790

4.  Within patient genetic diversity of blaKPC harboring Klebsiella pneumoniae in a Colombian hospital and identification of a new NTEKPC platform.

Authors:  Deisy Abril; Erika Vergara; Diana Palacios; Aura Lucía Leal; Ricaurte Alejandro Marquez-Ortiz; Johana Madroñero; Zayda Lorena Corredor Rozo; Zandra De La Rosa; Carlos A Nieto; Natasha Vanegas; Jorge A Cortés; Javier Escobar-Perez
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.